Interview with Francisco Billano, President, Interphil Laboratories
Interphil Laboratories has been active in the Philippines for a long time, having started in 1975 with the merger between Muller & Phipps. Can you give to our readers an…
Address: Canlubang Industrial Estate, Bo Pittland, 4025 Cabuyao, Laguna ,Philippines
Tel: +63 49 549-2345
Web: http://www.pharmaindustries.com/pi_home.html
Interphil Laboratories is a pharmaceutical contract manufacturer with a client-base of over 50 multinational companies, producing a wide range of healthcare products in many different forms, all in accordance with global standards. We have over 1,200 formulations currently in production in the largest, most advanced contract manufacturing facility in Asia.
Meeting the demands of our clients, Interphil Laboratories adheres to the highest standards of Quality Assurance. Our corporate policy of cGMP (current Good Manufacturing Practice) compliance is strictly enforced to ensure that the highest quality standards are applied in the preparation of only the safest, most efficacious products.
Interphil Laboratories has maintained a policy of not owning a proprietary brand in favor of safeguarding the confidentiality of clients’ manufacturing formulae.
Interphil Laboratories was born of the merger in 1978 between Pharma Industries Inc., a Zuellig-owned company established in the 1950’s, and Muller and Phipps, a US-owned company established in the 1940’s. The merged company was called Interphil and went public on the Philippines Stock Exchange in 1978.
Interphil Laboratories supports the supply chain of our clients with three core services: Product Development, Planning and Procurement and Contract Manufacturing. These services supply a competitive advantage for our clients by increasing available revenue streams, lowering costs and expanding a responsive production capacity.
Product development:
This service allows clients to develop line extensions and new pack sizes, and to receive assistance in the documentation licensing of existing formulations.
Planning & procurement:
This service offers clients customized materials, logistics planning and the benefits of group purchasing programs.
Toll manufacturing:
The multiple production facilities make possible the replication of manufacturing and packaging processes based on clients’ specifications.
Interphil Laboratories has been active in the Philippines for a long time, having started in 1975 with the merger between Muller & Phipps. Can you give to our readers an…
Teodoro Padilla, Executive Director at the Pharmaceutical and Healthcare Association of the Philippines, and Reiner Gloor, Advisor and Honorary Member, discuss the current objectives and goals of the association, how they are…
The expansion of universal healthcare coverage and significant growth in the use and acceptance of generics across the Philippines pose a significant challenge to the innovative medicines industry but also…
“The IMS Health figures show around three to four percent growth in the marketplace,” remarks Raymund Azurin, chief executive of Zuellig Pharma Philippines, “but we are now at a…
Before the introduction of universal healthcare (UHC), most major private hospitals in the Philippines had to rely on imported products. With the MNCs showing only limited interest in small volumes,…
The inclusion of healthcare as a priority on the presidential agenda has led to knock-on consequences that are being felt across the healthcare value chain in the Philippines. Universal…
Kenneth Y Hartigan-Go, Acting Director General of the Food and Drug Administration Philippines (FDA) discusses the current state of regulations processes, strategies that the FDA are applying to the major…
Armando Esguerra, President of Chira Pharmaceuticals, Philippines, explains the concept of chirality, why it is relevant and extremely important in the pharmaceutical industry, and what have been the major challenges…
Raymund Azurin of Zuellig Group, Philippines, discusses the potential opportunities in the Philippines’ emerging healthcare sector, the affect of the increasing use of health apps and electronic health records, and…
Gregorio (Greg) Navarro, Managing Partner & CEO of Deloitte Philippines, discusses the ASEAN region’s harmonization and what that means for the pharmaceutical industry, and further discusses the Philippines niche in…
Gregorio (Greg) Navarro, Managing Partner & CEO of Deloitte Philippines, discusses the ASEAN region’s harmonization and what that means for the pharmaceutical industry, and further discusses the Philippines niche in…
Jeffrey Williams, Assistant Vice President of Cognizant Philippines, talks about the high rate of Filipino nurses being outsourced to the US and other countries, the recent acquisition of the Medicall…
Earl Stanley Perez, General Manager of Meyerf Philippines, explains the importance of focusing on a few niches to succeed in a growing in a competitive market such as the Philippines,…
See our Cookie Privacy Policy Here
